|End-of-day quote - 09/18|
Takeda Pharmaceutical : Japan's Takeda to sell TachoSil surgical patch to Corza Health for 350 million euros
|09/16/2020 | 03:37am|
Takeda Pharmaceutical Co said on Wednesday it would sell its TachoSil surgical patch product to Corza Health for 350 million euros ($414.75 million) as the Japanese company continues to divest non-core businesses.
TachoSil, a surgical patch used for bleeding control
control, delivered $160 million in sales for Takeda in the fiscal year ended March 31, 2020, the company said in a release.
To reduce debt, Takeda has pledged to dispose of $10 billion worth of non-core assets.
Takeda is focusing on five key business areas: oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies.
($1 = 0.8439 euros)
(Reporting by Rocky Swift, editing by Louise Heavens)